BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11031854)

  • 1. [Levels of bactericidal antibodies against meningococcus C after vaccination in 2- to 6-year-old children in Andalusia].
    Delgado Torralbo E; Vazquez Moreno JA; García León J; González Enríquez J; Martínez Navarro F; Berrón Morato S; Mayoral Cortés JM; Rubin Gómez MA; Méndez Martínez C; Cortés Majó M; Chaves Caballero M; Bernal González ML
    Rev Esp Salud Publica; 2000; 74(4):433-44. PubMed ID: 11031854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of a serologic study after vaccination against serogroup C Neisseria meningitidis in children].
    Espín Ríos MI
    Rev Esp Salud Publica; 2000; 74(4):445-8. PubMed ID: 11031855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness and duration of the immunity of the vaccine against serogroup A+C meningococcus].
    García Comas L; Ramírez Fernández R; Castañeda López R; Sanz Moreno JC; Vázquez Moreno J; Lasheras Carbajo MD; Barranco Ordoñez D; Ruiz Contreras J; Jover Ibarra J
    Rev Esp Salud Publica; 2000; 74(4):425-31. PubMed ID: 11031853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Humoral immune response to the proteins of an antimeningococcal BC vaccine in a trial carried out in Antioquia, Colombia].
    Echeverry Uribe ML; Malberty Agüero JA; Galeano Marín LA; Sotolongo Padrón FT; Galguera Domínguez MA; Montoya Barrientos CM; Blanco González R; Martínez Ruiz O; Martínez Fernández OM; Aguirre Muñoz CA
    Bol Oficina Sanit Panam; 1995 Apr; 118(4):285-94. PubMed ID: 7779283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old children.
    Granoff DM; Morgan A; Welsch JA
    Vaccine; 2005 Jul; 23(34):4307-14. PubMed ID: 15921829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine.
    Sakou II; Tzanakaki G; Tsolia MN; Sioumala M; Barbouni A; Kyprianou M; Papaevangelou V; Tsitsika A; Blackwell CC; Kafetzis D; Kremastinou J
    Vaccine; 2009 Jul; 27(33):4408-11. PubMed ID: 19500554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.
    MacLennan J; Obaro S; Deeks J; Lake D; Elie C; Carlone G; Moxon ER; Greenwood B
    J Infect Dis; 2001 Jan; 183(1):97-104. PubMed ID: 11087205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.
    Borrow R; Goldblatt D; Andrews N; Richmond P; Southern J; Miller E
    J Infect Dis; 2001 Aug; 184(3):377-80. PubMed ID: 11443568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.
    Keyserling H; Papa T; Koranyi K; Ryall R; Bassily E; Bybel MJ; Sullivan K; Gilmet G; Reinhardt A
    Arch Pediatr Adolesc Med; 2005 Oct; 159(10):907-13. PubMed ID: 16203934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies.
    Rezaei N; Aghamohammadi A; Siadat SD; Nejati M; Ahmadi H; Moin M; Pourpak Z; Kamali S; Norouzian D; Tabaraei B; Read RC
    Vaccine; 2007 Jul; 25(29):5308-14. PubMed ID: 17574314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.
    Wong S; Lennon D; Jackson C; Stewart J; Reid S; Crengle S; Tilman S; Aaberge I; O'Hallahan J; Oster P; Mulholland K; Martin D
    Pediatr Infect Dis J; 2007 Apr; 26(4):345-50. PubMed ID: 17414400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine.
    Pichichero M; Papa T; Blatter M; Mitchell D; Kratz R; Sneed J; Bassily E; Casey J; Gilmet G
    Pediatr Infect Dis J; 2006 Nov; 25(11):995-1000. PubMed ID: 17072120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunogenecity induced by the VA-MENGOC-BC antimeningococcal vaccine against the ATCC C11. N. meningitidis strain in adolescents 12 years after being vaccinated].
    Camaraza MA; Ochoa R; Arnet AG; Sotolongo F; Martínez I; Cuevas I; Hernández D
    Rev Cubana Med Trop; 2004; 56(1):26-30. PubMed ID: 15849905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Humoral immune response to the capsular polysaccharide of Neisseria meningitidis serogroup C in an antimeningococcal BC vaccination trial in Antioquia, Colombia].
    Echeverry Uribe ML; Malberty Agüero JA; Galeano Marín LA; Sotolongo Padrón FT; Galguera Domínguez MA; Montoya Barrientos CM; Martínez Ruiz O; Nerey MC; Camarasa MA; Bacallao Gallestey J
    Bol Oficina Sanit Panam; 1995 Apr; 118(4):295-301. PubMed ID: 7779284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.
    Peltola H; Mäkelä H; Käyhty H; Jousimies H; Herva E; Hällström K; Sivonen A; Renkonen OV; Pettay O; Karanko V; Ahvonen P; Sarna S
    N Engl J Med; 1977 Sep; 297(13):686-91. PubMed ID: 408682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
    El Bashir H; Heath PT; Papa T; Ruggeberg JU; Johnson N; Sinha R; Balfour G; Booy R
    Vaccine; 2006 Mar; 24(14):2544-9. PubMed ID: 16417952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.
    Toropainen M; Saarinen L; Wedege E; Bolstad K; Mäkelä PH; Käyhty H
    Vaccine; 2005 Sep; 23(40):4821-33. PubMed ID: 15970361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seroprevalence of bactericidal anti-meningococcal antibodies in Cantabria 10 months following a vaccination campaign].
    González de Aledo Linos A; García Merino J
    Rev Esp Salud Publica; 1998; 72(4):365-74. PubMed ID: 9810841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term protection in children with meningococcal C conjugate vaccination: lessons learned.
    Borrow R; Miller E
    Expert Rev Vaccines; 2006 Dec; 5(6):851-7. PubMed ID: 17184222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.